Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

  1. Talukder, R.
  2. Makrakis, D.
  3. Lin, G.I.
  4. Diamantopoulos, L.N.
  5. Dawsey, S.
  6. Gupta, S.
  7. Carril-Ajuria, L.
  8. Castellano, D.
  9. de Kouchkovsky, I.
  10. Jindal, T.
  11. Koshkin, V.S.
  12. Park, J.J.
  13. Alva, A.
  14. Bilen, M.A.
  15. Stewart, T.F.
  16. McKay, R.R.
  17. Tripathi, N.
  18. Agarwal, N.
  19. Vather-Wu, N.
  20. Zakharia, Y.
  21. Morales-Barrera, R.
  22. Devitt, M.E.
  23. Cortellini, A.
  24. Fulgenzi, C.A.M.
  25. Pinato, D.J.
  26. Nelson, A.
  27. Hoimes, C.J.
  28. Gupta, K.
  29. Gartrell, B.A.
  30. Sankin, A.
  31. Tripathi, A.
  32. Zakopoulou, R.
  33. Bamias, A.
  34. Murgic, J.
  35. Fröbe, A.
  36. Rodriguez-Vida, A.
  37. Drakaki, A.
  38. Liu, S.
  39. Lu, E.
  40. Kumar, V.
  41. Lorenzo, G.D.
  42. Joshi, M.
  43. Isaacsson-Velho, P.
  44. Buznego, L.A.
  45. Duran, I.
  46. Moses, M.
  47. Barata, P.
  48. Sonpavde, G.
  49. Wright, J.L.
  50. Yu, E.Y.
  51. Montgomery, R.B.
  52. Hsieh, A.C.
  53. Grivas, P.
  54. Khaki, A.R.
  55. Erakutsi egile guztiak +
Aldizkaria:
Clinical Genitourinary Cancer

ISSN: 1938-0682,  1558-7673

Argitalpen urtea: 2022

Alea: 20

Zenbakia: 6

Orrialdeak: 558-567

Mota: Artikulua

DOI: 10.1016/J.CLGC.2022.08.006 GOOGLE SCHOLAR
Datuen iturria: Scopus